Xtx Topco LTD Acelrx Pharmaceuticals Inc Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.93 - $1.51 $27,350 - $44,407	-29,409 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$1.03 - $1.7 $2,203 - $3,636	-2,139 Reduced 6.78%	29,409 $41,000
Q1 2021 May 14, 2021	BUY	$1.25 - $2.77 $39,435 - $87,387	31,548 New	31,548 $54,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.